Main menu button

Equity Research KlaraBo, Q4 2024: 43% discount to NAV despite acquisitions and growth

Equity Research
4 Feb 2025

Read the preview here (Swedish)

Equity Research KlaraBo, Q4 2024: 43% discount to NAV despite acquisitions and growth
Bertil Nilsson
Bertil Nilsson LinkedIn
Senior Equity Analyst
+46 70 434 90 03
Markus Augustsson
Markus Augustsson LinkedIn
Head of Equity Research
+46 76 235 03 20

Similar News

Equity Research Immunovia: Second clinical validation of next-generation test
19 Mar 2025
Equity Research Immunovia: Second clinical validation of next-generation test
Equity Research Immunovia
Equity Research InCoax: Financials strengthened after weak Q4 2024
19 Mar 2025
Equity Research InCoax: Financials strengthened after weak Q4 2024
Equity Research InCoax
Analyse Lokotech: Finansiering og store rammeavtaler sikret
13 Mar 2025
Analyse Lokotech: Finansiering og store rammeavtaler sikret
Equity Research Lokotech
Equity Research Lokotech: Financing and framework agreements secured
13 Mar 2025
Equity Research Lokotech: Financing and framework agreements secured
Equity Research Lokotech
Research update Biosergen: Continued success in India and cash injection
07 Mar 2025
Research update Biosergen: Continued success in India and cash injection
Equity Research Biosergen